Unknown

Dataset Information

0

The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells.


ABSTRACT: Aberrant microRNA expression contributes to breast cancer progression and endocrine resistance. We reported that although tamoxifen stimulated miR-29b-1/a transcription in tamoxifen (TAM)-resistant breast cancer cells, ectopic expression of miR-29b-1/a did not drive TAM-resistance in MCF-7 breast cancer cells. However, miR-29b-1/a overexpression significantly repressed TAM-resistant LCC9 cell proliferation, suggesting that miR-29b-1/a is not mediating TAM resistance but acts as a tumor suppressor in TAM-resistant cells. The target genes mediating this tumor suppressor activity were unknown. Here, we identify miR-29b-1 and miR-29a target transcripts in both MCF-7 and LCC9 cells. We find that miR-29b-1 and miR-29a regulate common and unique transcripts in each cell line. The cell-specific and common downregulated genes were characterized using the MetaCore Gene Ontology (GO) enrichment analysis algorithm. LCC9-sepecific miR-29b-1/a-regulated GO processes include oxidative phosphorylation, ATP metabolism, and apoptosis. Extracellular flux analysis of cells transfected with anti- or pre- miR-29a confirmed that miR-29a inhibits mitochondrial bioenergetics in LCC9 cells. qPCR,luciferase reporter assays, and western blot also verified the ATP synthase subunit genes ATP5G1 and ATPIF1 as bone fide miR29b-1/a targets. Our results suggest that miR-29 repression of TAM-resistant breast cancer cell proliferation is mediated in part through repression of genes important in mitochondrial bioenergetics.

SUBMITTER: Muluhngwi P 

PROVIDER: S-EPMC5507892 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells.

Muluhngwi Penn P   Alizadeh-Rad Negin N   Vittitow Stephany L SL   Kalbfleisch Ted S TS   Klinge Carolyn M CM  

Scientific reports 20170712 1


Aberrant microRNA expression contributes to breast cancer progression and endocrine resistance. We reported that although tamoxifen stimulated miR-29b-1/a transcription in tamoxifen (TAM)-resistant breast cancer cells, ectopic expression of miR-29b-1/a did not drive TAM-resistance in MCF-7 breast cancer cells. However, miR-29b-1/a overexpression significantly repressed TAM-resistant LCC9 cell proliferation, suggesting that miR-29b-1/a is not mediating TAM resistance but acts as a tumor suppresso  ...[more]

Similar Datasets

| S-EPMC9307586 | biostudies-literature
| S-EPMC8307416 | biostudies-literature
| S-ECPF-GEOD-54891 | biostudies-other
| S-ECPF-GEOD-28645 | biostudies-other
| S-EPMC4302040 | biostudies-literature
2024-01-26 | PXD040478 | Pride
2014-02-27 | GSE54892 | GEO
| S-EPMC5089806 | biostudies-literature
| S-EPMC5544732 | biostudies-other
| S-EPMC4236860 | biostudies-literature